India urges TRIPs flexibility at the WTO to aid access to COVID-19 medicines. CNIPA announces its first COVID-19 vaccine patent application, and key global patent office initiatives are highlighted. The bulletin also provides updates on CNIPA’s budget and IPOPHL’s new patent search services.
Read more about India advocates TRIPs flexibility at the virtual WTO General Council Meeting, CNIPA publishes first patent application related to a vaccine for COVID-19 and more patent related newsCategory: Patents
Activity at IPO returns to near normal, 500+ grants in one week
The Indian patent office reported 739 applications published and 505 patents granted in a single week, indicating strong recovery in activity levels. This bulletin provides a comprehensive analysis of patent and design statistics compiled by BananaIP Counsels.
Read more about Activity at IPO returns to near normal, 500+ grants in one weekMammoth increase in patent grants and publications by IPO
The Indian Patent Office has reported a marked increase in both patent grants and publications for June 2020. Detailed statistics reveal significant growth across major cities and in industrial design registrations, reflecting current trends in India’s intellectual property landscape.
Read more about Mammoth increase in patent grants and publications by IPOCompulsory Licensing in India – Talk by Gaurav Mishra
Mr. Gaurav Mishra presented an in-depth session on compulsory licensing in India under the Patents Act at a DST Rajasthan event. The talk covered legal provisions, case studies, and the significance of compulsory licensing during the COVID-19 pandemic.
Read more about Compulsory Licensing in India – Talk by Gaurav MishraCOVID-19 patent pool opposed as Pfizer and AstraZeneca see no incentive and other patent news
This bulletin provides updates on the COVID-19 patent pool, opposition from leading pharmaceutical companies, and key patent law changes in India and abroad. It includes IPO e-filing developments, WHO C-TAP news, and significant international patent infringement cases.
Read more about COVID-19 patent pool opposed as Pfizer and AstraZeneca see no incentive and other patent newsPatent office sees overall decrease in activity this week
This weekly report examines a marked decrease in Indian patent office activity, with significant drops in both publications and grants. It also presents updated figures for design registrations and city-wise patent statistics, compiled by BananaIP Counsels.
Read more about Patent office sees overall decrease in activity this weekPatent Agent Examination 2020 postponed, Delhi High Court stays CGPDTM’s order and more
The Patent Agent Examination 2020 is postponed until further notice, and the Delhi High Court has stayed certain CGPDTM orders. The Indian Patent Office has extended all deadlines to 1st June 2020, while new IP law initiatives and international patent updates are also discussed.
Read more about Patent Agent Examination 2020 postponed, Delhi High Court stays CGPDTM’s order and morePatent grants increase by over 72% this week
This week’s Indian patent statistics reveal a notable 72 percent rise in grants and a substantial increase in published applications. The analysis also covers city-wise contributions and industrial design registrations, offering insight into current IP trends in India.
Read more about Patent grants increase by over 72% this weekPatent publications increase by over 60% this week
Indian patent publications have risen sharply this week, marking a 64.98 percent increase over the previous period. The report provides detailed statistical insights into patent grants, examination reports, and design registrations, reflecting current trends in Indian intellectual property filings.
Read more about Patent publications increase by over 60% this weekCOVID crisis threatens Gilead’s patent on Remdesvir, EPO’s Enlarged Board of Appeal issues opinion on plant and animal patentability, India asks G20 to establish agreement enabling use of TRIPS flexibilities and other patent news
The post analyses patent law updates relating to COVID-19, including India’s push for TRIPS flexibilities and scrutiny of Gilead’s Remdesvir patent. It also covers the EPO’s stance on plant and animal patentability and new global initiatives in IP law enforcement.
Read more about COVID crisis threatens Gilead’s patent on Remdesvir, EPO’s Enlarged Board of Appeal issues opinion on plant and animal patentability, India asks G20 to establish agreement enabling use of TRIPS flexibilities and other patent news